Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus

Circulation

Volumn 130, Issue 24, 2014, Pages 2143-2151

  Zhao, Wenhui ^a,b   Katzmarzyk, Peter T ^a   Horswell, Ronald ^a   Wang, Yujie ^a   Li, Weiqin ^a,c   Johnson, Jolene ^d   Heymsfield, Steven B ^a   Cefalu, William T ^a   Ryan, Donna H ^a   Hu, Gang ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c Tianjin Women and Children's Health Center   (China)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

body mass index; cohort studies; death; diabetes mellitus, type 2

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; BLACK PERSON; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CORRELATION ANALYSIS; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; AGED; COMPARATIVE STUDY; ETHNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; SURVIVAL RATE; VERY ELDERLY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84918517378     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009098     Document Type: Review

References (34)

1. Cheng YJ, Imperatore G, Geiss LS, Wang J, Saydah SH, Cowie CC, Gregg EW. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care. 2013;36:2690-2696.
2. Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, Sugawara A, Tanaka S, Shimano H, Iida KT, Saito K, Sone H. Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol. 2012;176: 959-969.
3. Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308:581-590.
4. Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular comorbidity: an analysis of the PROactive study population. Int J Cardiol. 2012;162:20-26.
5. Kokkinos P, Myers J, Faselis C, Doumas M, Kheirbek R, Nylen E. BMImortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2012;35:1021-1027.
6. McEwen LN, Kim C, Karter AJ, Haan MN, Ghosh D, Lantz PM, Mangione CM, Thompson TJ, Herman WH. Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care. 2007;30:1736-1741.
7. Jackson CL, Yeh HC, Szklo M, Hu FB, Wang NY, Dray-Spira R, Brancati FL. Body-mass index and all-cause mortality in US adults with and without diabetes. J Gen Intern Med. 2014;29:25-33.
8. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care. 2005;28:799-805.
9. Katzmarzyk PT, Hu G, Cefalu WT, Mire E, Bouchard C. The importance of waist circumference and BMI for mortality risk in diabetic adults. Diabetes Care. 2013;36:3128-3130.
10. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart. 2009;95:454-460.
11. So WY, Yang X, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Tong PC, Chan JC. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Metab Res Rev. 2008;24:238-246.
12. Tobias DK, Pan A, Jackson CL, OReilly EJ, Ding EL, Willett WC, Manson JE, Hu FB. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233-244.
13. McEwen LN, Karter AJ, Waitzfelder BE, Crosson JC, Marrero DG, Mangione CM, Herman WH. Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2012;35:1301-1309.
14. Li W, Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. Increasing prevalence of diabetes in middle or low income residents in Louisiana from 2000 to 2009. Diabetes Res Clin Pract. 2011;94:262-268.
15. Hu G, Horswell R, Wang Y, Li W, Besse J, Xiao K, Chen H, Keller JN, Heymsfield SB, Ryan DH, Katzmarzyk PT. Body mass index and the risk of dementia among Louisiana low income diabetic patients. PLoS One. 2012;7:e44537.
16. Zhang Y, Li W, Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. Increasing prevalence of hypertension in low income residents within Louisiana State University Health Care Services Division Hospital System. Eur J Intern Med. 2012;23:e179-e184.
17. Wang Y, Katzmarzyk PT, Horswell R, Li W, Xiao K, Besse J, Xie W, Johnson J, Heymsfield S, Ryan DH, Hu G. Racial disparities in diabetic complications in an underinsured population. J Clin Endocrinol Metab. 2012;97:4446-4453.
18. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Cefalu WT, Ryan DH, Hu G. Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab. 2013;98:3653-3662.
19. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care. 2013;36:3591-3598.
20. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and heart failure risk among diabetic patients. J Clin Endocrinol Metab. 2014;99:E263-E267.
21. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and coronary heart disease risk among diabetic patients. Diabetes Care. 2014;37:428-435.
22. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. Sex differences in the risk of stroke and HbA(1c) among diabetic patients. Diabetologia. 2014;57:918-926.
23. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care. 2013;36:3287-3296.
24. Wang Y, Katzmarzyk PT, Horswell R, Zhao W, Johnson J, Hu G. Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes. Kidney Int. 2014;85:1192-1199.
25. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
26. SAS Institute Inc. Chapter 66: The PHREG Procedure. In: SAS/STAT® 9.3 Users Guide. Cary, NC: SAS Institute Inc; 2011.
27. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
28. Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed. 1997;54:201-208.
29. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145-154.
30. Hu G, Heymsfield SB. Is mortality risk reduced in overweight or obese diabetics? J Gen Intern Med. 2014;29:3-4.
31. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71-82.
32. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197-1209.
33. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.
34. Bhaskaran K, Forbes HJ, Douglas I, Leon DA, Smeeth L. Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 2013;3:e003389.